Molekule Group, Inc. (USD) Molekule Group, Inc., founded in 2011 and based in Palm Beach Gardens, Florida, is a technology company specializing in advanced air purification systems for interior spaces. Previously operating as AeroClean Technologies, Inc. until its rebranding in January 2023, the company's primary mission is to provide air sterilization and disinfection solutions capable of eradicating dangerous airborne pathogens, including COVID-19, particularly within hospitals and other healthcare settings. A key product in their portfolio is Purgo (pronounced pure-go), a certified medical device that delivers continuous air filtration, sanitization, and supplemental ventilation. This innovative system, which incorporates their patented SteriDuct germicidal technology, is versatile enough for deployment in diverse indoor environments such as hospitals, corporate offices, and even elevators, aiming to minimize occupants' exposure to airborne particles and harmful pathogens. Molekule Group also offers a range of air purifiers designed for broader consumer and business markets. The Air Mini+, a direct-to-consumer model, includes a particle sensor, five distinct fan speeds, and an 'auto protect' mode for automatic speed adjustments. For larger areas, the Air Pro caters to both direct consumers and businesses, effectively purifying rooms up to 1,000 square feet. Furthermore, they provide the Air Pro Rx, a robust, medical-grade purifier specifically tailored for high-traffic zones in healthcare facilities, suitable for spaces exceeding 600 square feet. Complementing their purification devices, the company supplies advanced filtration components like the PECO-HEPA Tri-Power filter. They also offer digital tools such as the Molekule App, a mobile application that presents a 28-day historical overview of indoor air quality trends—including detected VOCs and particulate matter from PM 1 to PM 10—as sensed by the Air Pro purifier. For centralized management of multiple units, the Molekule Air Platform provides a dashboard interface for accessing data and controls.

Molekule Group, Inc. (USD) Passive

10455 Riverside Drive, Palm Beach Gardens, FL, US, 33410

Stock Price USD

Price Change

Last Dividend USD

MKUL's stock peer is BRDS (Bird Global, Inc.)

MKUL's stock peer is DCFCQ (Tritium DCFC Limited)

MKUL's stock peer is EFSH (1847 Holdings LLC)

MKUL's stock peer is HYREQ (HyreCar, Inc.)

MKUL's stock peer is OIG (Orbital Infrastructure Group, Inc.)

MKUL's stock peer is PIXY (ShiftPixy, Inc.)

MKUL's stock peer is SPEC (Spectaire Holdings Inc.)

MKUL's stock peer is WLGS (WANG & LEE GROUP, Inc.)

Industrials Industrial - Pollution & Treatment Controls

Molekule Group, Inc., founded in 2011 and based in Palm Beach Gardens, Florida, is a technology company specializing in advanced air purification systems for interior spaces. Previously operating as AeroClean Technologies, Inc. until its rebranding in January 2023, the company's primary mission is to provide air sterilization and disinfection solutions capable of eradicating dangerous airborne pathogens, including COVID-19, particularly within hospitals and other healthcare settings. A key product in their portfolio is Purgo (pronounced pure-go), a certified medical device that delivers continuous air filtration, sanitization, and supplemental ventilation. This innovative system, which incorporates their patented SteriDuct germicidal technology, is versatile enough for deployment in diverse indoor environments such as hospitals, corporate offices, and even elevators, aiming to minimize occupants' exposure to airborne particles and harmful pathogens. Molekule Group also offers a range of air purifiers designed for broader consumer and business markets. The Air Mini+, a direct-to-consumer model, includes a particle sensor, five distinct fan speeds, and an 'auto protect' mode for automatic speed adjustments. For larger areas, the Air Pro caters to both direct consumers and businesses, effectively purifying rooms up to 1,000 square feet. Furthermore, they provide the Air Pro Rx, a robust, medical-grade purifier specifically tailored for high-traffic zones in healthcare facilities, suitable for spaces exceeding 600 square feet. Complementing their purification devices, the company supplies advanced filtration components like the PECO-HEPA Tri-Power filter. They also offer digital tools such as the Molekule App, a mobile application that presents a 28-day historical overview of indoor air quality trends—including detected VOCs and particulate matter from PM 1 to PM 10—as sensed by the Air Pro purifier. For centralized management of multiple units, the Molekule Air Platform provides a dashboard interface for accessing data and controls.

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions